Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-006522
Filing Date
2023-12-28
Accepted
2023-12-28 16:22:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 12070
  Complete submission text file 0001950047-23-006522.txt   13517
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37891 | Film No.: 231522959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AC IMMUNE SA EPFL INNOVATION PARK BUILDING B 1015 LAUSANNE V8 00000
Business Address
Pfeifer Andrea (Reporting) CIK: 0001697107 (see all company filings)

Type: 144